VTRS•benzinga•
Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars
Summary
Viatris shares favorable Phase 3 data for contraceptive patch and pain drug, affirms 2025 sales, and raises adjusted EPS guidance.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga